已收盘 05-15 16:00:00 美东时间
-1.740
-4.04%
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
Goldman Sachs analyst Salveen Richter maintains Enliven Therapeutics (NASDAQ:ELVN) with a Buy and raises the price target from $41 to $59.
05-09 01:52
ALHC飙升16%,公司受益于CMS提高医疗保险支付额;潘兴广场拟高溢价收购环球音乐集团,UNVGY大涨13%;赫兹租车升逾10%,二手车价格上涨提升其车队投资回报率>>
04-08 19:09
药企并购潮来袭!Apellis制药飙升135%,获高额溢价收购;SpaceX已递交上市申请!FLY周涨38%,公司为NASA新一代登月火箭供应商;CNTA周涨38%,公司获礼来收购>>
03-28 11:01
今日重点评级关注:HC Wainwright & Co.:维持Atossa Therapeutics"买入"评级,目标价从7美元升至25美元;Needham:维持Nkarta"买入"评级,目标价从10美元升至11美元
03-27 10:22
今日重点评级关注:HC Wainwright & Co.:维持OCUGEN"买入"评级,目标价从7美元升至10美元;HC Wainwright & Co.:维持Maze Therapeutics"买入"评级,目标价从60美元升至110美元
03-26 11:41
Mizuho analyst Salim Syed maintains Enliven Therapeutics (NASDAQ:ELVN) with a Outperform and raises the price target from $41 to $45.
03-25 22:31
Enliven Therapeutics (NASDAQ:ELVN) released its Q4 earnings on Tuesday, March 3...
03-04 05:48
Enliven Therapeutics (NASDAQ:ELVN) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.38) by 27.32 percent. This is a 4.35 percent decrease over losses of $(0.46) per share
03-04 05:14
ANPA周涨近300%,公司获私募大额股份认购;脑再生科技涨超120%,马斯克“量产预告”催化脑机概念行情;Alumis周涨近120%,治疗银屑病新药临床成功>>
01-10 06:27